TrialCritical care (London, England)2020

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial.

Christopher Adlbrecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.